Last reviewed · How we verify

NCT03538132: PEPABIO

Patients' Perception on Bone Grafts

Completed Last updated 18 April 2019
What this trial tests

trial testing dental regenerative techniques in Dental Treatment in 100 participants. Completed in 30 December 2018.

Timeline
15 January 2018
Primary endpoint
30 September 2018
30 December 2018

Quick facts

Lead sponsorUniversity Hospital, Montpellier
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date15 January 2018
Primary completion30 September 2018
Estimated completion30 December 2018
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Montpellier

Who can join

18 and older, any sex, with Dental Treatment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to collect the patients' opinion about the different types of bone graft, to assess which are the most rejected by the patients and if the demographic variables (such as the gender or the age) and the level of education influence their decision.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Dental Treatment

Currently open trials in the same condition.

Other University Hospital, Montpellier trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03538132.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing